세계의 임상 실험실 검사 시장 (2024-2030) : 유형별 (전혈구수 (CBC), HGB/HCT 검사), 최종 용도별 (1차 진료소, 센트럴 랩), 지역별

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Clinical Laboratory Tests Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing geriatric population
3.2.1.2. Growing prevalence of target disease
3.2.1.3. Introduction of innovative solutions
3.2.2. Market restraint analysis
3.2.2.1. Presence of ambiguous regulatory framework
3.2.2.2. COVID-19 pandemic
3.3. Clinical Laboratory Tests Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Clinical Laboratory Tests Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Complete Blood Count
4.4.1.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.2. HGB/HCT Testing
4.4.2.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.3. Basic Metabolic Panel Testing
4.4.3.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.4. BUN Creatinine Testing
4.4.4.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.5. Electrolytes Testing
4.4.5.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.6. HbA1c Testing
4.4.7. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.8. Comprehensive Metabolic Panel Testing
4.4.8.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9. Liver Panel Testing
4.4.9.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9.2. Hepatitis
4.4.9.2.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9.3. Bile Duct Obstruction
4.4.9.3.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9.4. Liver Cirrhosis
4.4.9.4.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9.5. Liver Cancer
4.4.9.5.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9.6. Bone Disease
4.4.9.6.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9.7. Autoimmune Disorders
4.4.9.7.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.9.8. Others
4.4.9.8.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.10. Renal Panel Testing
4.4.10.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.11. Lipid Panel Testing
4.4.11.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
4.4.12. Cardiovascular Panel Testing
4.4.12.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
Chapter 5. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis
5.1. End-use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Clinical Laboratory Tests Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Central Laboratories
5.4.1.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
5.4.2. Primary Clinics
5.4.2.1. Market estimates and forecasts, 2018 – 2030 (USD Billion)
Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 – 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts, 2018 – 2030 (USD Billion)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts, 2018 – 2030 (USD Billion)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts, 2018 – 2030 (USD Billion)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts, 2018 – 2030 (USD Billion)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts, 2018 – 2030 (USD Billion)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts, 2018 – 2030 (USD Billion)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts, 2018 – 2030 (USD Billion)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts, 2018 – 2030 (USD Billion)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts, 2018 – 2030 (USD Billion)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts, 2018 – 2030 (USD Billion)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts, 2018 – 2030 (USD Billion)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts, 2018 – 2030 (USD Billion)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts, 2018 – 2030 (USD Billion)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 – 2030 (USD Billion)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts, 2018 – 2030 (USD Billion)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts, 2018 – 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. CINVEN
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. QUEST DIAGNOSTICS INCORPORATED
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. OPKO HEALTH, INC.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. F. Laboratory Corporation of America Holdings
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. UNILABS
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Synnovis Group LLP
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. SONIC HEALTHCARE
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives